A previous study on VP-16 mobilization in MM demonstrated that VP-16 successfully mobilized an adequate amount of stem cells (≥ 5.0 × 106 CD34+/kg) in patients who were previously given radiation therapy [13]. This evidence concerns the gene CD34 and Miyoshi myopathy.